SecBot SecBot
6-K ·Filed May 28, 2026

IMRN

Immuron Ltd
NEUTRAL
Impact 3/10
Horizondays Processed5mo ago SEC0001213900-26-061760
Notable filing: 6-K
Actionable Insight • Neutral

No new material information was disclosed. The price spike appears driven by retail interest following a May 8 CEO presentation. Monitor for any subsequent operational updates or clinical catalysts that could sustain momentum.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
IMRN ▼ -7.44% at T+60d
NEUTRAL call -7.44% · α vs SPY -9.17% · entry $1.21 → $1.12
Entry = T+0 close
May 28, 2026
via day close
T+1d
+19.83%
call +19.83% · α +19.59%
$1.45
settled 5mo ago
T+5d
+12.81%
call +12.81% · α +12.86%
$1.37
settled 5mo ago
T+20d
-9.09%
call -9.09% · α -5.95%
$1.10
settled 4mo ago
T+60d
-7.44%
call -7.44% · α -9.17%
$1.12
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Immuron filed a 6-K containing its response to an ASX price query regarding a sharp price spike from A$0.032 to A$0.044 on May 27-28, 2026. The company stated it is not aware of any undisclosed material information and attributed the trading activity to a CEO presentation at the Emerging Growth Conference on May 8, 2026. The filing is a routine regulatory response with no new material financial or operational information.

Key Facts

  • ASX queried a price move from A$0.032 to A$0.044 and a significant volume increase on May 27-28, 2026.
  • Immuron stated it is not aware of any undisclosed information that would explain the trading.
  • The company attributed the trading to a CEO presentation at the Emerging Growth Conference on May 8, 2026, previously disclosed.
  • Immuron confirmed compliance with ASX Listing Rule 3.1 (continuous disclosure).
  • The response was authorized by the Board of Directors.

Financial Impact

No financial figures reported; filing is a regulatory response with no new financial data.

Risk Factors

  • No material news to support the recent price increase — risk of mean reversion.
  • Micro-cap with $8M market cap is susceptible to volatile price swings on low volume.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001213900-26-061760
Document: ea0292481-6k_immuron.htm0001213900-26-061760
Document: 0001213900-26-061760-index-headers.html0001213900-26-061760
Document: 0001213900-26-061760-index.html0001213900-26-061760
Document: 0001213900-26-061760.txt0001213900-26-061760
26 reports for IMRN
Performance horizon
100% Hit rate @ T+60 4 of 4 directional calls Went positive at some point 4 of 4 best @ T+60▲ +29.44%Apr 17, 2026
Filters
Rows
Reports for IMRN — sortable, filterable
TypeNow
Oct 27, 2026
today
6-K
NEUTRAL ★ 4/10
$0.9300awaiting T+60—$0.9434 (+1.44%)
Oct 23, 2026
3d ago
6-K
NEUTRAL ★ 3/10
$0.9320awaiting T+60—$0.9434 (+1.22%)
Oct 23, 2026
3d ago
424B5
NEUTRAL ★ 3/10
$0.9320awaiting T+60—$0.9434 (+1.22%)
Oct 21, 2026
5d ago
6-K
NEUTRAL ★ 2/10
$0.9490awaiting T+60—$0.9434 (−0.59%)
Oct 16, 2026
11d ago
6-K
NEUTRAL ★ 3/10
$0.9821awaiting T+60—$0.9434 (−3.94%)
Oct 13, 2026
14d ago
6-K
NEUTRAL ★ 3/10
$1.04awaiting T+60—$0.9434 (−9.29%)
Sep 24, 2026
4w ago
20-F
MIXED ★ 5/10
$1.19awaiting T+60—$0.9434 (−20.72%)
Sep 24, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$1.19awaiting T+60—$0.9434 (−20.72%)
Sep 21, 2026
5w ago
6-K
NEUTRAL ★ 4/10
$1.26awaiting T+60—$0.9434 (−24.83%)
Sep 4, 2026
7w ago
Press Release
NEUTRAL ★ 4/10
$1.80awaiting T+60—$0.9434 (−47.59%)
Showing 10 of 26

US Market Status

Market Open — Closes in 1h 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 28, 2026